 "Alembic Pharma hits record high on heavy volumes")
Alembic Pharmaceuticals has rallied 5% to Rs 536, also its record high, after a huge block deal executed on the BSE in early morning trade.
At 0934 hours, around 621,269 equity shares representing 0.32% of total equity of Alembic Pharma have changed hands on the counter at price of Rs 516 per share, the BSE data shows.
The name of the buyers and sellers are not immediately known.
Meanwhile, the stock has outperformed the market by surging 19% in past three weeks from Rs 450 on April 28, 2015 after the US Food and Drug Administration (FDA) approved the first generic versions of Abilify (aripiprazole). The S&P BSE Sensex gained 1.3% during the same period.
The stock opened at Rs 512 and touched a low of Rs 507 on the BSE. A combined 896,108 shares changed hands on the counter so far as against an average around 150,000 shares were traded daily in past two weeks on the BSE and NSE.
At 1215 hours, the stock was up 3% at Rs 528 on the BSE.
At 0934 hours, around 621,269 equity shares representing 0.32% of total equity of Alembic Pharma have changed hands on the counter at price of Rs 516 per share, the BSE data shows.
The name of the buyers and sellers are not immediately known.
Meanwhile, the stock has outperformed the market by surging 19% in past three weeks from Rs 450 on April 28, 2015 after the US Food and Drug Administration (FDA) approved the first generic versions of Abilify (aripiprazole). The S&P BSE Sensex gained 1.3% during the same period.
The stock opened at Rs 512 and touched a low of Rs 507 on the BSE. A combined 896,108 shares changed hands on the counter so far as against an average around 150,000 shares were traded daily in past two weeks on the BSE and NSE.
At 1215 hours, the stock was up 3% at Rs 528 on the BSE.